Search Results1-4 of  4

  • Satake Hironaga ID: 9000403095089

    Articles in CiNii:1

    • Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (2018)
  • SATAKE Hironaga ID: 9000283216874

    Department of Medical Oncology, Kobe City Medical Center General Hospital (2015 from CiNii)

    Articles in CiNii:1

    • A case of jejunal ectopic pancreatic cancer: the diagnostic usefulness of MRI (2015)
  • Satake Hironaga ID: 9000402241338

    Department of Medical Oncology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Japan|Cancer Treatment Center, Kansai Medical University Hospital, Japan (2019 from CiNii)

    Articles in CiNii:1

    • Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with <i>ALK</i> mutation (2019)
  • Satake Hironaga ID: 9000403304474

    Department of Medical Oncology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Japan|Cancer Treatment Center, Kansai Medical University Hospital, Japan (2020 from CiNii)

    Articles in CiNii:1

    • Reduction and Escalation in the Dose of Sunitinib were Adequately Effective against Gastrointestinal Stromal Tumor of the Small Intestine: A Case Report (2020)
Page Top